Davy Chiodin, PharmD
Senior Vice President – Product Development
Day One Biopharmaceuticals
Dr.Davy Chiodin brings to Day One nearly 20 years of pharmaceutical industry experience and 15 years of oncology development experience, across tumor types and stages of development.
Prior to joining Day One, Davy was at Acerta, a member of the AstraZeneca group, where he led the Regulatory Science and Quality Assurance functions through the acalabrutinib global filings and the build of the AZ hematology franchise. Davy spent more than 10 years at Roche/Genentech, assuming roles of increased responsibility in the Regulatory function in both Europe and the US, including two years fully dedicated to the pediatric oncology portfolio. He has remained an active contributor to the pediatric oncology community since then.
Davy received his PharmD from the university of Grenoble, France, and a Master in Regulatory Affairs and Pharmacoeconomics from the universities of Lille and Paris, France.